A B S T R A C T The prostaglandin (PG) content of mitogen-and antigen-stimulated leukocyte cultures was examined by a radioimmunoassay procedure employing an antiserum reactive with PGB1 and PGB2, the alkaline dehydration products of PGE and PGA. At 48 h, mitogen-activated mouse spleen cell cultures showed 2-10-fold increases in the PGE, but not in the PGA, component of immunoreactive PG (iPG) fractionated by silicic acid column chromatography. Increases in iPG were detectable by h 16 in spleen cell cultures incubated with staphylococcal enterotoxin B. Since iPG levels rose only in the culture supernates and not in cells exposed to mitogens for 48 h, increases reflected extracellular release of PG. The validity of the radioimmunoassay determinations of PGE in spleen cell cultures was supported by the results of concomitant assessment of the PGE2 content of basal and enterotoxin-stimulated cultures by gas chromatography/mass spectrometry. By the latter method, the PGE2 content was three-fold higher in enterotoxin-activated, compared to basal, cultures at 48 h. Aspirin effectively suppressed increases in both iPG and PGE2. In spleen cell cultures prepared from mice previously inoculated with an attenuated strain of yellow fever virus in vivo and then incubated with this virus in vitro, iPG levels increased twofold over basal at 48 h. By contrast, iPG content of spleen cell cultures prepared from saline-inoculated mice was not appreciably altered by exposure to the virus in vitro.
The enhancement of iPG release from cultured spleen cells by mitogens did not correlate with an ability of these agents to increase cellular cyclic AMP (cAMP) levels. Moreover, epinephrine and cholera toxin markedly increased spleen cell cAMP content but had no demonstrable effect on basal iPG levels, suggesting iPG release from these cells was not mediated by cAMP.
Incubation with mitogens also enhanced the iPG content of 72-cultures of human peripheral leukocytes and of human lymphocytes isolated by nylon chromatography. However, the iPG of cultures of human lymphocytes purified by glass bead chromatography and of mouse thymocytes was not appreciably altered when these cells were cultured with mitogens, even though DNA synthesis in both instances was markedly increased. Accordingly, iPG release was not an invariable concomitant of increased DNA synthesis in lymphoid cell cultures.
In summary, the results demonstrate that mitogen and antigen stimulation of leukocytes in culture may be accompanied by enhanced release of PGE. The mechanisms mediating this phenomenon and its biologic significance remain to be delineated, but participation of PGE in immunologically induced inflammatory responses seems possible. leukocyte cultures have also been shown to be induced by prostaglandins (PG's).' These common biologic effects include enhancement of vascular permeability, vasodilation, leukotaxis, and initiation of bone resorption (3) (4) (5) (6) (7) (8) (9) (10) . In addition, PG's have been implicated both as mediators and modulators of several inflammatory processes (4, 7, 11) and have been identified in a wide variety of inflammatory exudates (4, 12, 13) . They may directly influence the function of both neutrophils and lymphocytes by activating the adenylate cyclase-cyclic adenosine 3',5'-monophosphate (cAMP) system of leukocytes (14) (15) (16) (17) . There is also evidence to suggest that release of PG's may occur in vivo in response to certain immunologic stimuli (4, 18, 19) . However, the possibility that PG's are released by immunologically activated leukocytes in culture has not been specifically examined.
In view of the above observations and the fact that PG's are, in general, synthesized and released locally at their cellular sites of action (18, 20, 21) , we assessed the PG content of mouse and human leukocyte cultures after mitogenic or antigenic stimulation in vitro.
METHODS
Preparation of cells. Spleen and thymus cells from 5 to 10-wk-old inbred male C57BL/6 mice' and human peripheral leukocytes from healthy young adult male donors were studied. Suspensions of spleen or thymus cells were prepared by methods previously described (22, 23) . Each organ was gently minced with scissors and the tissue fragments passed through a 60-mesh stainless steel screen into RPMI-1640 medium with 25 mM Hepes buffer.3 These fragments were drawn through a 25-gauge needle to produce a suspension of single cells. The latter were then washed with buffered RPMI-1640, centrifuged at 200 g, and resuspended in the complete lymphocyte culture medium described below. Antigen-sensitive spleen cells were obtained by inoculating mice intraperitoneally with 5 X 10' plaque-forming units of the 17D vaccine strain of yellow fever virus.' Mice were inoculated on day 0 and 7 with either virus or saline (controls), and spleens were harvested and studied on day 14 postinoculation.
Human peripheral leukocytes (approximately 60%o granulocytes and 40% mononuclear cells) were isolated from freshly drawn heparinized blood by dextran sedimentation (24) . Hypotonic lysis was employed to remove contaminating red cells. Purified human lymphocytes were prepared either by nylon chromatography or dextran-sedimented mixed leukocytes (24) or by glass bead chromatography (25) culture periods, and its incorporation was assessed by previously described methods (23) .
Extraction and conversion of PG. PG derived from the entire leukocyte culture, the culture supernate, or the resuspended leukocyte pellet was extracted by a two-step column chromatographic method. Cultures were acidified to pH 3 with 1 N HCl, homogenized, and poured onto 150 909. This value is consistent with previous findings (26) .
After evaporation and resuspension of the three PG fractions in 0.5 ml of 0.1 M Tris-HCl buffer (pH 7.4), each fraction was subjected to alkaline dehydration by adding 10 MAl of 1 N NaOH to the Tris suspension (final pH 11.5) and heating for 10 min at 950C. This procedure converts PG's of the E and A type to type B (27) antiserum to PGB18 (anti-PGB1) was employed to estimate the PG content of the three PG fractions after alkaline dehydration. Initially, standard curves were prepared over a concentration range of 0.01-10 ng/ml, using identical concentrations of both commercially available PGB1 and PGE1 which had been subjected to alkaline dehydration as described above. Since these standards were found to yield analogous curves, only known concentrations of alkaline, dehydrated PGE1 were then routinely employed; the unknowns and the standards to be assayed were subject to alkaline dehydration simultaneously. Gas chromatographic/mass spectrometric determination of PGEs. PGE2 content of the supernates from control and mitogen-stimulated mouse spleen cell cultures were determined by the general gas chromatographic/mass spectrometric method of Axen, Green, Horlin, and Samuelsson and Hammarstr6m and Samuelsson (28, 29) , except that preparative thin-layer chromatography, rather than reserved phase partition chromatography, was employed to purify PG extracts. The supernates from 10 spleen cell culture tubes (1.5 X 107 cell/3 ml medium) were pooled for a single determination of PGE2 content by gas chromatography/mass spectrometry. These measurements were most generously performed by Dr. Leon Wolfe of the Montreal Neurologic Institute, Montreal, Canada.
Determination of mouse spleen cell cAMP content. To assess the effects of test agents on cellular cAMP content, leukocyte cultures were centrifuged at 1,500 rpm for 2 min at 40C and the cell pellets immediately homogenized in 300 ,ul of hot sodium acetate buffer (pH 4.0, 50 mM) which contained 2,000 cpm of [1H]cAMP5 to assess recovery. These homogenates were heated for an additional 10 min at 950C and centrifuged at 3,500 rpm for 10 min. Aliquots (50 and 25 pi) of the supernates were then assayed directly for cAMP content by using the protein-binding method of Gilman (30 
RESULTS
Cross-reactivity of anti-PGBi antiserum. As shown in Fig. 1, [3H] PGB1 was most effectively displaced from the anti-PGBi antiserum by PGB1 (or alkaline, dehydrated PGE,). However, significant displacement was also observed with PGA1 and PGB2 (Fig. 1) . Approximately 5 ng/ml of PGA2, 10 ng/ml of PGE,, and 80 ng/ml of PGE2 were required to displace 50% of [8H] PGB1 from the antiserum, quantities at least 10- Since the antiserum employed was clearly not monospecific for PGB1 (Fig. 1) , experimental values for the PG content of leukocyte cultures are reported only as the immunoreactive PG (iPG) found in each of the silicic acid fractions.
PG content of mitogen-stimulated mouse lymphoid cell cultures. As shown in Table I , the iPG content of the PGE silicic acid fraction from 48-h mouse spleen cell cultures stimulated with the mitogens SEB, PHA, and CON-A was significantly increased. In four separate experiments, the magnitude of this increase in mitogenstimulated cultures ranged from 2-to 10-fold over control. No significant alterations in the iPG content of the PGA (Table I) or PGF (not shown) silicic acid fractions from stimulated cultures were detectable with the immunoassay method employed. As indicated in Table I , mouse spleen cell [3H]Tdr incorporation was concomitantly monitored and was markedly potentiated by all of the mitogens employed. The addition of a nonmitogenic protein, bovine serum albumin, to cultures altered neither iPG content nor [3H]Tdr incorporation, whereas the addition of aspirin suppressed both basal iPG and the increase in iPG observed in response to SEB (Table I ). In agreement with previous observations (32), the dose of salicylate employed in the present study (30 ug/ml) did not adversely affect cell viability as assessed by trypan blue exclusion at the end of the culture period, although [3H]Tdr incorporation was modestly reduced.
As also shown in Table I , the increase in iPG content of SEB-treated spleen cell cultures was attributable to release of PG into the culture medium, since the content of the latter, but not of the cell pellet, was enhanced after stimulation with SEB. Similar results were obtained with PHA and CON-A. Addition of mitogens alone in the absence of added spleen cells did not detectably influence the iPG content of the culture medium (not shown). Further, SEB and CON-A failed to increase the iPG of either the PGE or A silicic acid fraction from mouse thymus cell cultures. However, were extracted for iPG.
[3H]Tdr was added at h 0; * indicates P < 0.01 compared to control value at the same hour.
[3H]Tdr incorporation by thymus cells exposed to these mitogens was clearly increased (Table I) . Fig. 2 depicts the time-course of changes in the iPG content of spleen cell cultures stimulated with SEB. A significant increase in the iPG content of the PGE silicic acid fraction was noted as early as 16 h after the initiation of the cultures. At this time, moderate increases in [3H]Tdr incorporation (< two-fold over control) were observed in cells exposed to SEB. Comparable results were obtained when [3H]Tdr incorporation was assessed sequentially in SEB-stimulated cells incubated with the labeled nucleotide for 3 h before harvest rather than for the entire culture period (increase in [3H1 Tdr incorporation over control, two-fold at 16 and 24 h, 13-fold at 36 h, and 17-fold at 48 h').
PG content of antigen-stimulated mouse spleen cell cultures. As shown in Table II Determination of PGE2 by gas chromatography/mass spectrometry. Table III compares changes in the iPG content of the PGE silicic acid fraction of supernates from spleen cell cultures to alterations in the PGE2 content of these supernates as determined by gas chromatography/mass spectrometry. A clear increase of comparable magnitude occurred in both these parameters in cultures stimulated with SEB. Increases in both parameters were suppressed by aspirin (Table III) .
In view of the differences in methodology and the demonstrated cross-reactivity of the antiserum employed in the immunoassay procedure (Fig. 1) , the close correspondence in the absolute values obtained is likely coincidental. However, the results suggest that the increase in iPG in SEB-stimulated cultures may, at least in part, be due to enhanced release of PGE2. Alterations in the PGE1, A, or A2 content of the cultures could not be specifically determined by gas chromatography/mass spectrometry. However, preliminary findings with this method have suggested an increase in the PGF2 content of mitogen-stimulated cultures (not shown). cAMP content of spleen cells. Spleen cell cAMP content (mean basal±SE, 9.2±0.6 pmol/107 cells) was significantly enhanced by 5 /g/ml epinephrine (16.5± 1.3 at 10 min) and 5 4ug/ml of cholera toxin (123.6± 9.4 at 1 h) but was not altered by SEB, CON-A, or PHA. By contrast, neither epinephrine nor cholera toxin detectably influenced basal iPG release by spleen cells when the latter was assessed at 10 min, 1 h, or 48 h of culture. Further, incubation of spleen cells with both SEB and cholera toxin suppressed iPG release at 48 h (mean+SE, 0.91±0.10 ng released/1.5 X 107 cells/3 ml culture medium) compared to that observed in response to SEB alone (3.25±0.30), P < 0.01. The latter effect of cholera toxin on SEB-stimulated cultures was accompanied by a 72% reduction in [3H]Tdr incorporation.
PG content of human peripheral leukocyte and lymphocyte cultures. As shown in Table IV , the iPG content of the PGE silicic acid fraction of cultures of mixed human leukocyte populations (approximately 60% granulocytes and 40% mononuclear cells) was increased by mitogenic stimuli. This increase in iPG was suppressed by aspirin, which in the dose employed (30 jeg/ml) also resulted in a slight decrease in
[3H]Tdr incorporation. The iPG content of culture of human peripheral lymphocytes, prepared by nylon coltumn chromatography, was also enhanced, but the magnitude of the change was less than that observed with heterogeneous leukocyte preparations (Table IV) . By contrast, mitogens did not detectably influence the iPG content of cultures of lymphocytes which had been purified by glass bead chromatography. However, [3H]-Tdr incorporation by these lymphocytes was clearly potentiated by mitogens (Table IV) . The cells employed in the three experiments shown in Table IV were isolated from separate donors, but similar results were observed when each experiment was repeated twice using lymphocytes from different donors. The iPG content of the PGA fraction of stimulated human leukocyte or lymphocyte cultures was not significantly different from that of control cultures (not shown).
DISCUSSION
The results indicate that the PGE content of leukocyte cultures is enhanced by mitogenic and antigenic stimulation. Using an antiserum reactive with both PGBi and B2, the alkaline dehydration products of PGE1 and E2, increased quantities of immunoreactive prostaglandin were detected in the alkaline, dehydrated PGE silicic acid fractions from both stimulated mouse and human leukocyte cultures. Moreover, by gas chromatographic/ mass spectrometric analysis a specific increase in the PGE2 content of SEB-stimulated mouse spleen cultures Table I . * Difference from corresponding control significant at P < 0.001.
4 Dose of PHA refers to Al of reconstituted commercial extract/ml of culture medium. § Difference from SEB alone significant at P < 0.01.
was observed, which corresponded in magnitude to the increase in the iPG content of the PGE silicic acid fraction of these cultures. By contrast, no significant increase in the iPG content of the PGA silicic acid fractions of stimulated leukocyte cultures was noted following alkaline dehydration, even though the latter procedure is known to convert PGA1 and A2 to PGB1 and B2 (27) . The antiserum employed in the present study demonstrated little cross-reactivity with PGF10 or F2t.
Accordingly, the possibility of an alteration in the PGF levels of stimulated cultures is not excluded by the radioimmunoassay findings, and, indeed, preliminary assessment of PGF2. content by gas chromatography/mass spectrometry suggests that this moiety may also be increased in mitogen-stimulated mouse spleen cell cultures.
Separate analysis of the iPG content of the leukocyte pellets and of the culture supernates after mitogenic stimulation (Table I ) demonstrated that the elevated iPG observed in extracts from whole cultures was owing entirely to an increase in media iPG, a finding which implies extracellular release of PG by stimulated leukocytes. The ability to suppress the iPG content of stimulated cultures with aspirin, an inhibitor of prostaglandin synthesis (33) , not only supports the validity of the iPG determinations but also indicates that the increases in prostaglandin were mediated, at least in part, by de novo cellular synthesis. These findings are consistent with previous studies demonstrating that prostaglandins are not stored in cells but formed immediately before release, probably from fatty acid precursors derived from the phospholipids of cell membranes (21) .
It is tempting to speculate that enhanced synthesis and release of PG's in stimulated leukocyte cultures may be a function of the activated lymphocytes in these cultures. The 16-h latent period between exposure of spleen cell cultures to mitogens and detection of a significant increase in iPG content (Fig. 2) (34) (35) (36) . Whether this in fact accounts for the failure to observe iPG release from some populations of activated lymphoid cells remains conjectural.
In a number of tissues, increased intracellular cAMP levels are thought to initiate release of PG's including those of the E type (37) (38) (39) . However, in cultured leukocytes release of PGE did not appear to be mediated by cAMP. Mitogenic agents effective in enhancing PGE release did not detectably influence the cAMP levels of mouse spleen cells. Moreover, cholera toxin and epinephrine, agents which markedly increased lymphoid cell cAMP content, did not stimulate prostaglandin release. Although cholera toxin is thought to initiate prostaglandin release from certain tissues, such as intestinal mucosa (37, 40) , this agent actually suppressed mitogen-induced release of iPG from lymphocytes. The latter action of cholera toxin is quite likely related to cAMP-mediated inhibition of lymphoid cell activation (41, 42) . Since prostaglandins appear to be derived from cell membrane phospholipid (21) , it is possible that mitogens induce release of these agents through effects on membrane phospholipid metabolism (43), rather than through cAMP. In this regard, it has been suggested that activation of phospholipase may be an initial action of agents which trigger the release of PG (21) .
The physiologic significance of the release of PGE by leukocytes upon stimulation in vitro is uncertain. Cultured human and mouse cells other than leukocytes have also been shown to release PG's (29, 44, 45) , and release of these agents by some types of neoplastically transformed cells appears to be accentuated (44, 46, 47) . Accordingly, enhanced release of prostaglandin does not qualify as a response which is unique to immunologically stimulated leukocytes in culture. Nevertheless, in view of the known influences of these agents on inflammatory and immune processes (4, 11) , it seems possible that release of specific PG's from immunologically activated leukocytes might be of functional consequence. For example, PGE1 or E2 appear capable of mediating certain of the biologic actions known to be associated with the supernates from mitogen-or antigenactivated lymphoid cell cultures. In particular, PGE1 and Ea both enhance vascular permeability (4, 5) and the resorption of bone (10) . Supernates from stimulated cultures also induce these same responses (1) (2) (3) , and the soluble mediators responsible have not been well characterized. Alternatively, the PGE released by im-munologic stimuli might ultimately act to modulate an ensuing inflammatory response. At high doses, PGEi and E2 have been shown to inhibit the morphologic transformation and cytotoxic activity of lymphocytes (16, 17, 42) , as well as lysosomal enzyme and histamine release from other leukocytes (15, 48) . By such actions, locally released PGE, if present in sufficient quantity, might participate in a negative feedback inhibition system acting to limit the inflammatory process.
It is clear that delineation of the biologic significance of the release of prostaglandin from immunologically activated leukocytes in culture will require more precise quantitation of the specific prostaglandin moieties released and evidence that similar events occur in vivo. The results of the present study suggest that a further evaluation of this response is warranted.
